Shares of a few biotechnology companies and vaccine makers soared on Wednesday after the U.S. Senate approved Project BioShield, which will fund research to detect and protect against a potential bioterror attack.
Shares of a few biotechnology companies and vaccine makers soared on Wednesday after the U.S. Senate approved Project BioShield, which will fund research to detect and protect against a potential bioterror attack.
